The COVID-19 Antigen Test Kit is used for the qualitative detection
of nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab
samples from individuals suspected of COVID-19, only for in vitro
diagnostic use.
The novel coronaviruses belong to the β genus. COVID-19 is an acute
respiratory infectious disease. People are generally susceptible.
Currently, the patients infected by the novel coronavirus are the
main source of infection; asymptomatic infected people can also be
an infectious source. Based on the current epidemiological
investigation, the incubation period is 1 to 14 days, mostly 3 to 7
days. The main manifestations include fever, fatigue, and dry
cough. Nasal congestion, runny nose, sore throat, myalgia, and
diarrhea are found in a few cases.
Antigen is generally detectable in upper respiratory specimens
during the acute phase of infection. Rapid diagnosis of SARS-CoV-2
infection will help healthcare professionals to treat patients and
control the disease more efficiently and effectively.
Biovantion Inc is independent from international department of
Bioneovan Co., Ltd., which established in 2 0 0 5, is an in vitro
diagnostic reagents manufacturer engaged in the research,
development, production, and focus on clinical testing for
infectious diseases, such as Hepatitis virus, Noro virus, Parvo
virus test kits, our products include rapid test cassette and Elisa
kits.
All our products have been registered in National Medical Products
Administration of China, in year 2020 we get Certificate of ISO
13485:2016 – QUALITY MANAGEMENT SYSTEMS FOR MEDICAL DEVICES from
SGS. More importantly, we have awarded the registration certificate
from National Medical Products Administration for Diagnostic Kit
for IgM Antibody to COVID-19 and IgG antibody to COVID-19 during
the outbreak in China, and also we developed COVID-19 Antigen test
; Neutralizing Antibody Test, these products selling well all
overthe world
